Article Information
History
- February 11, 2019.
Article Versions
- You are currently viewing Version 1 of this article (February 11, 2019 - 14:55).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lisanne F. van Dessel1,a,
- Job van Riet2,3,a,
- Minke Smits4,
- Yanyun Zhu5,6,
- Paul Hamberg7,
- Michiel S. van der Heijden8,9,10,
- Andries M. Bergman5,10,
- Inge M. van Oort11,
- Ronald de Wit1,
- Emile E. Voest8,10,
- Neeltje Steeghs8,10,
- John W.M. Martens1,8,
- Stefan Sleijfer1,8,
- Edwin Cuppen12,
- Wilbert Zwart5,6,13,
- Harmen J.G. van de Werken2,3,
- Niven Mehra4,b and
- Martijn P. Lolkema1,8,b,*
- 1Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands
- 2Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands
- 3Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, Rotterdam, the Netherlands
- 4Department of Medical Oncology, Radboud University Nijmegen Medical Center, Geert Grooteplein Zuid 10 6525 GA Nijmegen, the Netherlands
- 5Division on Oncogenomics, The Netherlands Cancer Institute, Plesmanlaan 121 1066 CX Amsterdam, the Netherlands
- 6Oncode Institute, the Netherlands
- 7Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Kleiweg 500 3045 PM Rotterdam, the Netherlands
- 8Center for Personalized Cancer Treatment, Rotterdam, the Netherlands
- 9Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121 1066 CX Amsterdam, the Netherlands
- 10Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121 1066 CX Amsterdam, the Netherlands
- 11Department of Urology, Radboud University Nijmegen Medical Center, Geert Grooteplein Zuid 10 6525 GA Nijmegen, the Netherlands
- 12Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
- 13Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, PO Box 513, Eindhoven
- ↵*Corresponding author: Address for correspondence:
Martijn P. Lolkema. Department of Medical Oncology, Erasmus MC Cancer Institute, Room NT-537, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Tel.: +31 10 704 19 06. E-mail: m.lolkema{at}erasmusmc.nl